Oruka Therapeutics Inc (ORKA)
20.50
-1.70
(-7.66%)
USD |
NASDAQ |
Nov 21, 16:00
18.52
-1.98
(-9.66%)
After-Hours: 05:39
Oruka Therapeutics Enterprise Value: 309.53M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 309.53M |
| November 20, 2024 | 369.02M |
| November 19, 2024 | 372.52M |
| November 18, 2024 | 331.58M |
| November 15, 2024 | 433.42M |
| November 14, 2024 | 432.02M |
| November 13, 2024 | 489.77M |
| November 12, 2024 | 505.52M |
| November 11, 2024 | 523.72M |
| November 08, 2024 | 525.82M |
| November 07, 2024 | 488.72M |
| November 06, 2024 | 559.42M |
| November 05, 2024 | 526.17M |
| November 04, 2024 | 535.27M |
| November 01, 2024 | 543.67M |
| October 31, 2024 | 572.02M |
| October 30, 2024 | 602.82M |
| October 29, 2024 | 640.96M |
| October 28, 2024 | 652.51M |
| October 25, 2024 | 571.67M |
| October 24, 2024 | 631.51M |
| October 23, 2024 | 641.66M |
| October 22, 2024 | 648.66M |
| October 21, 2024 | 659.16M |
| October 18, 2024 | 633.61M |
| Date | Value |
|---|---|
| October 17, 2024 | 600.37M |
| October 16, 2024 | 607.37M |
| October 15, 2024 | 565.72M |
| October 14, 2024 | 562.92M |
| October 11, 2024 | 503.42M |
| October 10, 2024 | 502.02M |
| October 09, 2024 | 588.12M |
| October 08, 2024 | 554.87M |
| October 07, 2024 | 502.02M |
| October 04, 2024 | 483.47M |
| October 03, 2024 | 473.67M |
| October 02, 2024 | 467.02M |
| October 01, 2024 | 458.27M |
| September 30, 2024 | 449.87M |
| September 27, 2024 | 808.88M |
| September 26, 2024 | 845.28M |
| September 25, 2024 | 844.23M |
| September 24, 2024 | 844.58M |
| September 23, 2024 | 870.13M |
| September 20, 2024 | 884.83M |
| September 19, 2024 | 878.53M |
| September 18, 2024 | 898.13M |
| September 17, 2024 | 936.27M |
| September 16, 2024 | 916.32M |
| September 13, 2024 | 880.98M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
309.53M
Minimum
Nov 21 2024
936.27M
Maximum
Sep 17 2024
629.53M
Average
594.24M
Median
Enterprise Value Benchmarks
| LENZ Therapeutics Inc | 726.72M |
| TruBridge Inc | 406.63M |
| PetMed Express Inc | 43.84M |
| Streamline Health Solutions Inc | 21.68M |
| R1 RCM Inc | 8.087B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -28.62M |
| Total Expenses (Quarterly) | 29.45M |
| EPS Diluted (Quarterly) | -1.46 |